L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 2.84 EUR
Market Cap: 20.5m EUR

Wall Street
Price Targets

LAB Price Targets Summary
Labiana Health SA

There are no price targets for LAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Labiana Health SA Competitors:
Price Targets
4536
Santen Pharmaceutical Co Ltd
50% Upside
GLS
Glenmark Life Sciences Ltd
10% Upside
4540
Tsumura & Co
39% Upside
ZTS
Zoetis Inc
35% Upside
1093
CSPC Pharmaceutical Group Ltd
31% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Labiana Health SA

For the last 4 years the compound annual growth rate for Labiana Health SA's revenue is 5%. The projected CAGR for the next 3 years is 13%.

5%
Past Growth
13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Labiana Health SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Labiana Health SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LAB's stock price target?
Not Available

LAB doesn't have any price targets made by Wall Street professionals.

What is Labiana Health SA's Revenue forecast?
Projected CAGR
13%

For the last 4 years the compound annual growth rate for Labiana Health SA's revenue is 5%. The projected CAGR for the next 3 years is 13%.

Back to Top